1. Home
  2. KGEI vs MDWD Comparison

KGEI vs MDWD Comparison

Compare KGEI & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KGEI
  • MDWD
  • Stock Information
  • Founded
  • KGEI 2008
  • MDWD 2000
  • Country
  • KGEI United States
  • MDWD Israel
  • Employees
  • KGEI N/A
  • MDWD N/A
  • Industry
  • KGEI
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • KGEI
  • MDWD Health Care
  • Exchange
  • KGEI Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • KGEI 254.9M
  • MDWD 208.2M
  • IPO Year
  • KGEI N/A
  • MDWD 2014
  • Fundamental
  • Price
  • KGEI $6.10
  • MDWD $18.66
  • Analyst Decision
  • KGEI Strong Buy
  • MDWD Strong Buy
  • Analyst Count
  • KGEI 1
  • MDWD 2
  • Target Price
  • KGEI $11.00
  • MDWD $35.00
  • AVG Volume (30 Days)
  • KGEI 149.4K
  • MDWD 68.7K
  • Earning Date
  • KGEI 08-11-2025
  • MDWD 08-14-2025
  • Dividend Yield
  • KGEI N/A
  • MDWD N/A
  • EPS Growth
  • KGEI 42.32
  • MDWD N/A
  • EPS
  • KGEI 0.57
  • MDWD N/A
  • Revenue
  • KGEI $60,739,000.00
  • MDWD $19,213,000.00
  • Revenue This Year
  • KGEI $19.44
  • MDWD $20.64
  • Revenue Next Year
  • KGEI $38.49
  • MDWD $25.71
  • P/E Ratio
  • KGEI $10.54
  • MDWD N/A
  • Revenue Growth
  • KGEI 20.06
  • MDWD N/A
  • 52 Week Low
  • KGEI $2.85
  • MDWD $14.14
  • 52 Week High
  • KGEI $9.89
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • KGEI 49.20
  • MDWD 41.12
  • Support Level
  • KGEI $5.70
  • MDWD $17.60
  • Resistance Level
  • KGEI $6.18
  • MDWD $19.12
  • Average True Range (ATR)
  • KGEI 0.23
  • MDWD 0.79
  • MACD
  • KGEI 0.03
  • MDWD -0.15
  • Stochastic Oscillator
  • KGEI 61.43
  • MDWD 37.84

About KGEI Kolibri Global Energy Inc. Common stock

Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: